metoprolol has been researched along with Secondary Hyperparathyroidism in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fournier, A | 1 |
Coevoet, B | 1 |
de Fremont, JF | 1 |
Gueris, J | 1 |
Caillens, G | 1 |
Desplan, C | 1 |
Calmette, C | 1 |
Moukhtar, MS | 1 |
Takeda, K | 1 |
Kusano, E | 1 |
Asano, Y | 1 |
Hosoda, S | 1 |
2 other studies available for metoprolol and Secondary Hyperparathyroidism
Article | Year |
---|---|
Propranolol therapy for secondary hyperparathyroidism in uraemia.
Topics: Calcitonin; Drug Therapy, Combination; Humans; Hyperparathyroidism, Secondary; Metoprolol; Parathyro | 1978 |
Beta-antagonist and secondary hyperparathyroidism in chronic renal failure.
Topics: Adult; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Metoprolol; Mi | 1985 |